nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

07.12.2022

Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain Injury

verfasst von: Sophie Samuel, Carlton Menchaca, Aaron M. Gusdon

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Highlights

Venous Thromboembolism is one of the common complications seen in hospitalized patients leading to increased mortality and morbidity.

Early initiation of anticoagulation for management of venous thromboembolism in brain injury patients is challenging due to the risk of hemorrhagic complications.

The results from this study suggest that early use of anticoagulation for venous thrombosis was not associated with poor functional outcomes.

Larger studies are warranted to assess the safety of early initiation of anticoagulation therapy in this patient population.

Cai Q, Zhang X, Chen H (2021) Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J 19(1):93. https://doi.org/10.1186/s12959-021-00345-zCrossRefPubMedPubMedCentral

Hawryluk GW, Furlan JC, Austin JW, Fehlings MG (2011) Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal. World Neurosurg 76(3–4):299–303. https://doi.org/10.1016/j.wneu.2011.03.034CrossRefPubMed

Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH (2014) Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med 174(8):1244–1251. https://doi.org/10.1001/jamainternmed.2014.2534CrossRefPubMedPubMedCentral

Matsushima K, Inaba K, Cho J, Mohammed H, Herr K, Leichtle S, Zada G, Demetriades D (2016) Therapeutic anticoagulation in patients with traumatic brain injury. J Surg Res 205(1):186–191. https://doi.org/10.1016/j.jss.2016.06.042CrossRefPubMed

Puckett Y, Zhang K, Blasingame J, Lorenzana J, Parameswaran S, Brooks SE, Baronia BC, Griswold J (2018) Safest time to resume oral anticoagulation in patients with traumatic brain Injury. Cureus 10(7):e2920. https://doi.org/10.7759/cureus.2920CrossRefPubMedPubMedCentral

Tykocki T, Guzek K (2016) Anticoagulation Therapy in Traumatic Brain Injury. World Neurosurg 89:497–504. https://doi.org/10.1016/j.wneu.2016.01.063CrossRefPubMed

Hawryluk GW, Austin JW, Furlan JC, Lee JB, O’Kelly C, Fehlings MG (2010) Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 8(7):1500–1508. https://doi.org/10.1111/j.1538-7836.2010.03882.xCrossRefPubMed

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ et al (2015) Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial. Trials 16:393. https://doi.org/10.1186/s13063-015-0898-4CrossRefPubMedPubMedCentral

Diringer MN, Bleck TP, Claude Hemphill J 3rd et al (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211–240. https://doi.org/10.1007/s12028-011-9605-9

10.

Carney N, Totten AM, O’Reilly C et al (2017) Guidelines for the management of severe traumatic brain Injury, Fourth Edition. Neurosurgery 80(1):6–15. https://doi.org/10.1227/NEU.0000000000001432CrossRefPubMed

11.

Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and Prevention of thrombosis, 9th ed: american college of chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226. https://doi.org/10.1378/chest.11-2296CrossRefPubMedPubMedCentral

12.

Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (6 Suppl):381S-453S. https://doi.org/10.1378/chest.08-0656

13.

Hemphill JC, Greenberg SM, Anderson CS et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 46(7):2032–2060. https://doi.org/10.1161/STR.0000000000000069CrossRefPubMed

14.

Steiner T, Kaste M, Forsting M et al (2006) Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The european Stroke Initiative writing Committee and the writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22(4):294–316. https://doi.org/10.1159/000094831CrossRefPubMed

15.

Nguyen NY, Frishman WH (2020) Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage. Cardiol Rev 2020;28(4):190–196. https://doi.org/10.1097/CRD.0000000000000288

16.

Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY (2015) Restarting anticoagulant treatment after Intracraniala Hemorrhage in patients with Atrial Fibrillation and the impact on recurrent stroke, mortality, and bleeding: a Nationwide Cohort Study. Circulation 132(6):517–525. https://doi.org/10.1161/CIRCULATIONAHA.115.015735CrossRefPubMed

17.

Ottosen TP, Grijota M, Hansen ML et al (2016) Use of Antithrombotic Therapy and Long-Term Clinical Outcome among Patients surviving Intracerebral Hemorrhage. Stroke 47(7):1837–1843. https://doi.org/10.1161/STROKEAHA.116.012945CrossRefPubMed

18.

Byrnes MC, Irwin E, Roach R, James M, Horst PK, Reicks P (2012) Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J Emerg Surg 7(1):25. https://doi.org/10.1186/1749-7922-7-25CrossRefPubMedPubMedCentral

19.

Appendix C: VTE Measurement and Tracking. Content last reviewed May 2016. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/patient-safety/resources/vtguide/appc.html

20.

The Joint Commission (2018) Specifications Manual for Joint Commission National Quality Measures – Modified Rankin Score (mRS). Accessed September 7, 2021. https://manual.jointcommission.org/releases/TJC2018A/DataElem0569.html

21.

Bailey RD, Hart RG, Benavente O, Pearce LA (2001) Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56:773–777. https://doi.org/10.1212/WNL.56.6.773

22.

Passero S, Burgalassi L, D’andrea P, Battistini N (1995) Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26:1189–1192. https://doi.org/10.1161/01.STR.26.7.1189

23.

Cosgrove GR, Leblanc R, Meagher-Villemure K, Ethier R (1985) Cerebral amyloid angiopathy. Neurology 35:625–631. https://doi.org/10.1212/WNL.35.5.625

24.

Kearon C, Akl EA, Ornelas J, (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315–352. https://doi:https://doi.org/10.1016/j.chest.2015.11.026

25.

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921), 955–962. https://doi.org/10.1016/S0140-6736(13)62343-0

26.

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100. https://doi:https://doi.org/10.1378/chest.10-0134

27.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. https://doi:https://doi.org/10.1378/chest.09-1584

Titel: Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain Injury
verfasst von: Sophie Samuel
Carlton Menchaca
Aaron M. Gusdon
Publikationsdatum: 07.12.2022
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 2/2023
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-022-02745-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Highlights

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review

Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery

Percutaneous thrombectomy in patients with intermediate- and high-risk pulmonary embolism and contraindications to thrombolytics: a systematic review and meta-analysis

Impact of a pharmacist intervention on DOAC knowledge and satisfaction in ambulatory patients

Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study

Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura